CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $168,000 | -77.0% | 378,732 | -57.9% | 0.00% | – |
| Q1 2017 | $731,000 | +105.9% | 899,398 | +79.3% | 0.00% | – |
| Q4 2016 | $355,000 | -37.5% | 501,608 | -9.9% | 0.00% | – |
| Q3 2016 | $568,000 | -50.7% | 556,488 | +2.6% | 0.00% | – |
| Q2 2016 | $1,151,000 | +12.5% | 542,631 | +43.8% | 0.00% | – |
| Q1 2016 | $1,023,000 | +24.5% | 377,450 | +28.6% | 0.00% | – |
| Q4 2015 | $822,000 | -99.5% | 293,504 | -94.1% | 0.00% | -100.0% |
| Q3 2015 | $167,007,000 | +22777.7% | 4,961,914 | +3029.2% | 0.01% | – |
| Q2 2015 | $730,000 | +114.7% | 158,567 | +319.7% | 0.00% | – |
| Q1 2015 | $340,000 | +82.8% | 37,781 | +26.0% | 0.00% | – |
| Q4 2014 | $186,000 | +72.2% | 29,981 | +17.2% | 0.00% | – |
| Q3 2014 | $108,000 | – | 25,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $6,612,000 | 6.88% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $15,123,000 | 6.74% |
| Cormorant Asset Management, LP | 551,354 | $2,536,000 | 0.34% |
| Deer VII & Co. Ltd. | 166,675 | $767,000 | 0.31% |
| Rock Springs Capital Management LP | 625,000 | $2,875,000 | 0.21% |
| WALL STREET ASSOCIATES | 475,000 | $2,185,000 | 0.21% |
| CLOUGH CAPITAL PARTNERS L P | 276,400 | $1,271,000 | 0.05% |
| TFS CAPITAL LLC | 103,648 | $477,000 | 0.05% |
| Granahan Investment Management | 332,225 | $1,528,000 | 0.04% |
| Northeast Financial Consultants Inc | 20,000 | $92,000 | 0.04% |